Wellness Tier Procedure Category

Peptide Therapy

BPC-157, TB-500, GHK-Cu, CJC/ipamorelin, PT-141, tesamorelin, NAD+

Peptide therapy is the highest-growth cash-pay wellness category in the United States and one of the least transparent. Most peptides are obtained through compounding pharmacies, often via telehealth clinics, with prices varying 3x or more between providers for the same molecule. The regulatory landscape has shifted significantly: the FDA reclassified several common peptides (BPC-157, CJC-1295 with DAC, ipamorelin) in 2023-2024, removing them from 503A compounding eligibility, and clinics have responded with varying degrees of compliance. ProcedureFinder provides neutral, evidence-anchored coverage of what each peptide claims to do, what published research shows, current legal status, and what reputable clinics charge.

Regulatory Notice

Many peptides exist in a complex regulatory space. The FDA reclassified BPC-157, CJC-1295 with DAC, and ipamorelin in 2023-2024, removing them from 503A compounding eligibility. Some peptides remain available through research-only channels or non-compliant compounders. ProcedureFinder publishes current legal status alongside each peptide page.

Cost range

$80 - $1,500

Procedures tracked

Metro markets

Cost pages

100

Procedures in Peptides

In-depth cost guides for the most-searched peptides procedures.

BPC-157 Peptide Therapy

A 15-amino-acid pentadecapeptide derived from a gastric protein, marketed for tendon, ligament, and gut healing. Currently restricted by FDA from 503A compounding.

National range $250 - $1,200

View costs →

CJC-1295 / Ipamorelin Peptide Therapy

Combination growth hormone-releasing peptide protocol marketed for improved sleep, recovery, body composition, and anti-aging. FDA-restricted from 503A compounding since 2023.

National range $350 - $1,200

View costs →